In addition, Sarikaya et al retrospectively analyzed the usefulness of PET for patients with CRC and suspected tumor recurrence, but normal CEA levels, and found that the overall accuracy of PET was 76.9%, and the positive predictive value was 84.6%. The gene discussed is CEACAM5; the disease is neoplasm.